Shares of UiPath Inc
UiPath filed its quarterly results on Wednesday, amid an exciting earnings season. Here are some key analyst takeaways from the earnings release.
- RBC Capital Markets analyst Matthew Hedberg maintained a Sector Perform rating, while raising the price target from $18 to $19.
- BMO Capital Markets analyst Keith Bachman reiterated a Market Perform rating, while lifting the price target from $18 to $19.
"At a high level, AI continues to be an integral piece of the long-term thesis as management believes that success thus far is reflected in this quarter's 30%+ $1M+ customer growth," the analyst wrote. "There has also been good progress around GTM enhancements and a healthy pipeline building into 2H/24."
BMO Capital Markets: UiPath's margin performance and guidance were "particularly strong," Bachman said. Management's ARR guidance "appears achievable and conservative."
Although the company delivered steady results for the past few quarters, concerns around the longer-term impact of GenAI and competition from Microsoft Corp
PATH Price Action: Shares of UiPath rose by 1.23% to $16.42 at the time of publication Thursday.